Funding Growth The organization operates with a mid-range nonprofit revenue in the 1M–10M band and has an active fundraising history including major campaigns like ALL IN, indicating continued capacity and appetite for partnerships, sponsorships, or grant-based collaborations.

Strategic Grants Recent and notable grants and alliances, such as the $200K MD Anderson collaboration and the TBXT Challenge with philanthropic partners, suggest opportunities for research partnerships, co-funded studies, and sponsor-driven initiatives in chordoma drug discovery and translational science.

Innovation Focus A track record of launching programs (Online training, Survivorship Initiative) and targeted research initiatives signals openness to technology-enabled solutions, data platforms, patient registry tools, and digital engagement offerings for research support and patient care.

Community Reach With a global patient base and partnerships with healthcare providers and industry, there is strong potential for vendor relationships that support patient advocacy platforms, education programs, and community engagement services.

Nonprofit Expertise Smaller team size (11–50 employees) combined with proven fundraising leadership suggests a high value in scalable, cost-effective services such as grant management, donor relationship systems, impact reporting, and shared services for nonprofits.